Circulation: Genomic and Precision Medicine最新文献

筛选
英文 中文
Yield of Genetic Testing for Long-QT Syndrome in Elderly Patients With Torsades de Pointes. 长 QT 综合征老年 Torsades de Pointes 患者基因检测的收效。
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-29 DOI: 10.1161/CIRCGEN.124.004671
Daiki Tomidokoro, Toshihiro Nakamura, Satoshi Oka, Yuichiro Miyazaki, Akionori Wakamiya, Nobuhiko Ueda, Kenzaburo Nakajima, Tsukasa Kamakura, Mitsuru Wada, Kohei Ishibashi, Yuko Inoue, Koji Miyamoto, Satoshi Nagase, Shuichi Kitada, Yu Sakaue, Hirokazu Shiraishi, Tomoyuki Kabutoya, Kaoru Takami, Miwa Miyoshi, Naohiko Takahashi, Takeshi Soeki, Yukio Hiroi, Yoshihiro Asano, Seiko Ohno, Kengo Kusano, Takeshi Aiba
{"title":"Yield of Genetic Testing for Long-QT Syndrome in Elderly Patients With Torsades de Pointes.","authors":"Daiki Tomidokoro, Toshihiro Nakamura, Satoshi Oka, Yuichiro Miyazaki, Akionori Wakamiya, Nobuhiko Ueda, Kenzaburo Nakajima, Tsukasa Kamakura, Mitsuru Wada, Kohei Ishibashi, Yuko Inoue, Koji Miyamoto, Satoshi Nagase, Shuichi Kitada, Yu Sakaue, Hirokazu Shiraishi, Tomoyuki Kabutoya, Kaoru Takami, Miwa Miyoshi, Naohiko Takahashi, Takeshi Soeki, Yukio Hiroi, Yoshihiro Asano, Seiko Ohno, Kengo Kusano, Takeshi Aiba","doi":"10.1161/CIRCGEN.124.004671","DOIUrl":"https://doi.org/10.1161/CIRCGEN.124.004671","url":null,"abstract":"","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Disease Pathogenicity Predictor (CVD-PP): A Tissue-Specific In Silico Tool for Discriminating Pathogenicity of Variants of Unknown Significance in Cardiovascular Disease Genes. 心血管疾病致病性预测因子(CVD-PP):一种组织特异性硅学工具,用于判别心血管疾病基因中意义不明变异的致病性。
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-29 DOI: 10.1161/CIRCGEN.123.004464
Megan E Ramaker, Jawan W Abdulrahim, Kristin M Corey, Ryne C Ramaker, Lydia Coulter Kwee, William E Kraus, Svati H Shah
{"title":"Cardiovascular Disease Pathogenicity Predictor (CVD-PP): A Tissue-Specific In Silico Tool for Discriminating Pathogenicity of Variants of Unknown Significance in Cardiovascular Disease Genes.","authors":"Megan E Ramaker, Jawan W Abdulrahim, Kristin M Corey, Ryne C Ramaker, Lydia Coulter Kwee, William E Kraus, Svati H Shah","doi":"10.1161/CIRCGEN.123.004464","DOIUrl":"https://doi.org/10.1161/CIRCGEN.123.004464","url":null,"abstract":"<p><strong>Background: </strong>Interpretation of variants of uncertain significance (VUSs) remains a challenge in the care of patients with inherited cardiovascular diseases (CVDs); 56% of variants within CVD risk genes are VUS, and machine learning algorithms trained upon large data resources can stratify VUS into higher versus lower probability of contributing to a CVD phenotype.</p><p><strong>Methods: </strong>We used ClinVar pathogenic/likely pathogenic and benign/likely benign variants from 47 CVD genes to build a predictive model of variant pathogenicity utilizing measures of evolutionary constraint, deleteriousness, splicogenicity, local pathogenicity, cardiac-specific expression, and population allele frequency. Performance was validated using variants for which the ClinVar pathogenicity assignment changed. Functional validation was assessed using prior studies in >900 identified VUS. The model utility was demonstrated using the Catheterization Genetics cohort.</p><p><strong>Results: </strong>We identified a top-ranked model that accurately prioritized variants for which ClinVar clinical significance had changed (n=663; precision-recall area under the curve, 0.97) and performed well compared with conventional in silico methods. This model (CVD pathogenicity predictor) also had high accuracy in prioritizing VUS with functional effects in vivo (precision-recall area under the curve, 0.58). In Catheterization Genetics, there was a greater burden of higher CVD pathogenicity predictor scored VUS in individuals with dilated cardiomyopathy compared with controls (<i>P</i>=8.2×10<sup>-</sup><sup>15</sup>). Of individuals in Catheterization Genetics who harbored highly ranked CVD pathogenicity predictor VUS meeting clinical pathogenicity criteria, 27.6% had clinical evidence of disease. Variant prioritization using this model increased genetic diagnosis in Catheterization Genetics participants with a known clinical diagnosis of hypertrophic cardiomyopathy (7.8%-27.2%).</p><p><strong>Conclusions: </strong>We present a cardiac-specific model for prioritizing variants underlying CVD syndromes with high performance in discriminating the pathogenicity of VUS in CVD genes. Variant review and phenotyping of individuals carrying VUS of pathogenic interest support the clinical utility of this model. This model could also have utility in filtering variants as part of large-scale genomic sequencing studies.</p>","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic Risk in Families With Dilated Cardiomyopathy. 扩张型心肌病家族的多基因风险
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-26 DOI: 10.1161/CIRCGEN.124.004558
Jamie-Lee M Thompson, Renee Johnson, Michael Troup, Emma M Rath, Paul E Young, Magdalena J Soka, Monique Ohanian, Ingrid S Tarr, Eleni Giannoulatou, Diane Fatkin
{"title":"Polygenic Risk in Families With Dilated Cardiomyopathy.","authors":"Jamie-Lee M Thompson, Renee Johnson, Michael Troup, Emma M Rath, Paul E Young, Magdalena J Soka, Monique Ohanian, Ingrid S Tarr, Eleni Giannoulatou, Diane Fatkin","doi":"10.1161/CIRCGEN.124.004558","DOIUrl":"10.1161/CIRCGEN.124.004558","url":null,"abstract":"","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic Scoring for Detection of Ascending Thoracic Aortic Dilation. 检测升主动脉扩张的多基因评分法
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-26 DOI: 10.1161/CIRCGEN.123.004512
John DePaolo, Gina Biagetti, Renae Judy, Grace J Wang, John J Kelly, Amit Iyengar, Nicholas J Goel, Nimesh D Desai, Wilson Y Szeto, Joseph E Bavaria, Michael G Levin, Scott M Damrauer
{"title":"Polygenic Scoring for Detection of Ascending Thoracic Aortic Dilation.","authors":"John DePaolo, Gina Biagetti, Renae Judy, Grace J Wang, John J Kelly, Amit Iyengar, Nicholas J Goel, Nimesh D Desai, Wilson Y Szeto, Joseph E Bavaria, Michael G Levin, Scott M Damrauer","doi":"10.1161/CIRCGEN.123.004512","DOIUrl":"10.1161/CIRCGEN.123.004512","url":null,"abstract":"<p><strong>Background: </strong>Ascending thoracic aortic dilation is a complex heritable trait that involves modifiable and nonmodifiable risk factors. Polygenic scores (PGS) are increasingly used to assess risk for complex diseases. The degree to which a PGS can improve aortic diameter prediction in diverse populations is unknown. Presently, we tested whether adding a PGS to clinical prediction algorithms improves performance in a diverse biobank.</p><p><strong>Methods: </strong>The analytic cohort comprised 6235 Penn Medicine Biobank participants with available echocardiography and clinical data linked to genome-wide genotype data. Linear regression models were used to integrate PGS weights derived from a genome-wide association study of thoracic aortic diameter performed in the UK Biobank and were compared with the performance of the previously published aorta optimized regression for thoracic aneurysm (AORTA) score.</p><p><strong>Results: </strong>Cohort participants had a median age of 61 years (IQR, 53-70) and a mean ascending aortic diameter of 3.36 cm (SD, 0.49). Fifty-five percent were male, and 33% were genetically similar to an African reference population. Compared with the AORTA score, which explained 30.6% (95% CI, 29.9%-31.4%) of the variance in aortic diameter, AORTA score+UK Biobank-derived PGS explained 33.1%, (95% CI, 32.3%-33.8%), the reweighted AORTA score explained 32.5% (95% CI, 31.8%-33.2%), and the reweighted AORTA score+UK Biobank-derived PGS explained 34.9% (95% CI, 34.2%-35.6%). When stratified by population, models including the UK Biobank-derived PGS consistently improved upon the clinical AORTA score among individuals genetically similar to a European reference population but conferred minimal improvement among individuals genetically similar to an African reference population. Comparable performance disparities were observed in models developed to discriminate cases/noncases of thoracic aortic dilation (≥4.0 cm).</p><p><strong>Conclusions: </strong>We demonstrated that inclusion of a UK Biobank-derived PGS to the AORTA score confers a clinically meaningful improvement in model performance only among individuals genetically similar to European reference populations and may exacerbate existing health care disparities.</p>","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common SYNE2 Genetic Variant Associated With Atrial Fibrillation Lowers Expression of Nesprin-2α1 With Downstream Effects on Nuclear and Electrophysiological Traits. 与心房颤动有关的常见 SYNE2 基因变异会降低 Nesprin-2α1 的表达,并对核和电生理特征产生下游影响。
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-10-02 DOI: 10.1161/CIRCGEN.124.004750
Nana Liu, Jeffrey Hsu, Gautam Mahajan, Han Sun, Kenneth R Laurita, Sathyamangla V Naga Prasad, John Barnard, David R Van Wagoner, Chandrasekhar R Kothapalli, Mina K Chung, Jonathan D Smith
{"title":"Common <i>SYNE2</i> Genetic Variant Associated With Atrial Fibrillation Lowers Expression of Nesprin-2α1 With Downstream Effects on Nuclear and Electrophysiological Traits.","authors":"Nana Liu, Jeffrey Hsu, Gautam Mahajan, Han Sun, Kenneth R Laurita, Sathyamangla V Naga Prasad, John Barnard, David R Van Wagoner, Chandrasekhar R Kothapalli, Mina K Chung, Jonathan D Smith","doi":"10.1161/CIRCGEN.124.004750","DOIUrl":"10.1161/CIRCGEN.124.004750","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation GWAS (genome-wide association studies) identified significant associations for rs1152591 and linked variants in the <i>SYNE2</i> gene encoding Nesprin-2, which connects the nuclear membrane with the cytoskeleton.</p><p><strong>Methods: </strong>Reporter gene vector transfection and CRISPR-Cas9 editing were used to identify the causal variant regulating the expression of <i>SYNE2α1</i>. After <i>SYNE2</i> knockdown or <i>SYNE2α1</i> overexpression in human stem cell-derived cardiomyocytes, nuclear phenotypes were assessed by imaging and atomic force microscopy. Gene expression was assessed by RNAseq and gene set enrichment analysis. Fura-2 AM staining assessed calcium transients. Optical mapping assessed action potential duration and conduction velocity.</p><p><strong>Results: </strong>The risk allele of rs1152591 had lower promoter and enhancer activity and was significantly associated with lower expression of the short <i>SYNE2α1</i> isoform in human stem cell-derived cardiomyocytes, without an effect on the expression of the full-length <i>SYNE2</i> mRNA. <i>SYNE2α1</i> overexpression had dominant negative effects on the nucleus with its overexpression or <i>SYNE2</i> knockdown leading to increased nuclear area and decreased nuclear stiffness. Gene expression results from <i>SYNE2α1</i> overexpression demonstrated both concordant and nonconcordant effects with <i>SYNE2</i> knockdown. <i>SYNE2α1</i> overexpression had a gain of function on electrophysiology, leading to significantly faster calcium reuptake and decreased assessed action potential duration, while <i>SYNE2</i> knockdown showed both shortened assessed action potential duration and decreased conduction velocity.</p><p><strong>Conclusions: </strong>rs1152591 was identified as a causal atrial fibrillation variant, with the risk allele decreasing <i>SYNE2α1</i> expression. Downstream effects of <i>SYNE2α1</i> overexpression include changes in nuclear stiffness and electrophysiology, which may contribute to the mechanism for the risk allele's association with AF.</p>","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522946/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Calmodulin in Cardiac Disease: Insights on Genotype and Phenotype. 钙调蛋白在心脏病中的作用:基因型和表型的启示
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-09 DOI: 10.1161/CIRCGEN.124.004542
Peter J Schwartz, Lia Crotti, Mette Nyegaard, Michael Toft Overgaard
{"title":"Role of Calmodulin in Cardiac Disease: Insights on Genotype and Phenotype.","authors":"Peter J Schwartz, Lia Crotti, Mette Nyegaard, Michael Toft Overgaard","doi":"10.1161/CIRCGEN.124.004542","DOIUrl":"10.1161/CIRCGEN.124.004542","url":null,"abstract":"<p><p>Calmodulin, a protein critically important for the regulation of all major cardiac ion channels, is the quintessential cellular calcium sensor and plays a key role in preserving cardiac electrical stability. Its unique importance is highlighted by the presence of 3 genes in 3 different chromosomes encoding for the same protein and by their extreme conservation. Indeed, all 3 calmodulin (<i>CALM</i>) genes are among the most constrained genes in the human genome, that is, the observed variants are much less than expected by chance. Not surprisingly, <i>CALM</i> variants are poorly tolerated and accompany significant clinical phenotypes, of which the most important are those associated with increased risk for life-threatening arrhythmias. Here, we review the current knowledge about calmodulin, its specific physiological, structural, and functional characteristics, and its importance for cardiovascular disease. Given our role in the development of this knowledge, we also share some of our views about currently unanswered questions, including the rational approaches to the clinical management of the affected patients. Specifically, we present some of the most critical information emerging from the International Calmodulinopathy Registry, which we established 10 years ago. Further progress clearly requires deep phenotypic information on as many carriers as possible through international contributions to the registry, in order to expand our knowledge about Calmodulinopathies and guide clinical management.</p>","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia. 蛋白质组和转录组全遗传分析确定了子痫前期的生物通路和候选药物靶点。
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-09 DOI: 10.1161/CIRCGEN.124.004755
Maddalena Ardissino, Buu Truong, Eric A W Slob, Art Schuermans, Satoshi Yoshiji, Alec P Morley, Stephen Burgess, Fu Siong Ng, Antonio de Marvao, Pradeep Natarajan, Kypros Nicolaides, Liam Gaziano, Adam Butterworth, Michael C Honigberg
{"title":"Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia.","authors":"Maddalena Ardissino, Buu Truong, Eric A W Slob, Art Schuermans, Satoshi Yoshiji, Alec P Morley, Stephen Burgess, Fu Siong Ng, Antonio de Marvao, Pradeep Natarajan, Kypros Nicolaides, Liam Gaziano, Adam Butterworth, Michael C Honigberg","doi":"10.1161/CIRCGEN.124.004755","DOIUrl":"10.1161/CIRCGEN.124.004755","url":null,"abstract":"<p><strong>Background: </strong>Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality. However, the current understanding of its underlying biological pathways remains limited.</p><p><strong>Methods: </strong>In this study, we performed a cross-platform proteome- and transcriptome-wide genetic analysis aimed at evaluating the causal relevance of >2000 circulating proteins with preeclampsia, supported by data on the expression of over 15 000 genes across 36 tissues leveraging large-scale preeclampsia genetic association data from women of European ancestry.</p><p><strong>Results: </strong>We demonstrate genetic associations of 18 circulating proteins with preeclampsia (SULT1A1 [sulfotransferase 1A1], SH2B3 [SH2B adapter protein 3], SERPINE2 [serpin family E member 2], RGS18 [regulator of G-protein signaling 18], PZP [pregnancy zone protein], NOTUM [notum, palmitoleoyl-protein carboxylesterase], METAP1 [methionyl aminopeptidase 1], MANEA [mannosidase endo-alpha], jun-D [JunD proto-oncogene], GDF15 [growth differentiation factor 15], FGL1 [fibrinogen like 1], FGF5 [fibroblast growth factor 5], FES [FES proto-oncogene], APOBR [apolipoprotein B receptor], ANP [natriuretic peptide A], ALDH-E2 [aldehyde dehydrogenase 2 family member], ADAMTS13 [ADAM metallopeptidase with thrombospondin type 1 motif 13], and 3MG [N-methylpurine DNA glycosylase]), among which 11 were either directly or indirectly supported by gene expression data, 9 were supported by Bayesian colocalization analyses, and 5 (SERPINE2, PZP, FGF5, FES, and ANP) were supported by all lines of evidence examined. Protein interaction mapping identified potential shared biological pathways through natriuretic peptide signaling, blood pressure regulation, immune tolerance, and thrombin activity regulation.</p><p><strong>Conclusions: </strong>This investigation identified multiple targetable proteins linked to cardiovascular, inflammatory, and coagulation pathways, with SERPINE2, PZP, FGF5, FES, and ANP identified as pivotal proteins with likely causal roles in the development of preeclampsia. The identification of these potential targets may guide the development of targeted therapies for preeclampsia.</p>","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7616531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise Intolerance and Low Cardiac Filling Pressures in a Woman With a Novel eNOS Mutation. 一名 eNOS 基因突变女性的运动不耐受和低心脏充盈压。
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-27 DOI: 10.1161/CIRCGEN.124.004741
Sarah McGarrity, David R Ziehr, Christina A Austin-Tse, Marc N Wein, Raghu R Chivukula, William M Oldham
{"title":"Exercise Intolerance and Low Cardiac Filling Pressures in a Woman With a Novel eNOS Mutation.","authors":"Sarah McGarrity, David R Ziehr, Christina A Austin-Tse, Marc N Wein, Raghu R Chivukula, William M Oldham","doi":"10.1161/CIRCGEN.124.004741","DOIUrl":"10.1161/CIRCGEN.124.004741","url":null,"abstract":"","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Normal Is Low-Normal Left Ventricular Ejection Fraction in Familial Dilated Cardiomyopathy? 家族性扩张型心肌病左心室射血分数过低有多正常?
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-08 DOI: 10.1161/CIRCGEN.124.004603
Stacey A Peters, Leah Wright, Samuel J Fogarty, Lauren McCall, Maraed Rosa, Subodh B Joshi, Elaine Lui, Dominica Zentner, Tom Marwick, Diane Fatkin
{"title":"How Normal Is Low-Normal Left Ventricular Ejection Fraction in Familial Dilated Cardiomyopathy?","authors":"Stacey A Peters, Leah Wright, Samuel J Fogarty, Lauren McCall, Maraed Rosa, Subodh B Joshi, Elaine Lui, Dominica Zentner, Tom Marwick, Diane Fatkin","doi":"10.1161/CIRCGEN.124.004603","DOIUrl":"10.1161/CIRCGEN.124.004603","url":null,"abstract":"","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death. 循环血浆分析揭示了蛋白质组特征和 SVEP1 在心脏性猝死中的因果作用
IF 6 2区 医学
Circulation: Genomic and Precision Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-05 DOI: 10.1161/CIRCGEN.123.004494
ThuyVy Duong, Thomas R Austin, Jennifer A Brody, Ali Shojaie, Alexis Battle, Joel S Bader, Yun Soo Hong, Christie M Ballantyne, Josef Coresh, Robert E Gerszten, Russell P Tracy, Bruce M Psaty, Nona Sotoodehnia, Dan E Arking
{"title":"Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death.","authors":"ThuyVy Duong, Thomas R Austin, Jennifer A Brody, Ali Shojaie, Alexis Battle, Joel S Bader, Yun Soo Hong, Christie M Ballantyne, Josef Coresh, Robert E Gerszten, Russell P Tracy, Bruce M Psaty, Nona Sotoodehnia, Dan E Arking","doi":"10.1161/CIRCGEN.123.004494","DOIUrl":"10.1161/CIRCGEN.123.004494","url":null,"abstract":"","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信